Men's attitudes regarding genetic testing for hereditary prostate cancer risk

Urology

Volumn 55, Issue 1, 2000, Pages 46-50

  Miesfeldt, Susan ^a   Jones, Susan M ^b   Cohn, Wendy ^c   Lippert, Marguerite ^c   Haden, Kathleen ^b   Turner, Beverely L ^a   Martin Fries, Tracee ^c   Clark, Stephanie M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER RISK; CANCER SCREENING; DIET; DISEASE PREDISPOSITION; ETHNOLOGY; FAMILIAL CANCER; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADULT; AGED; AGED, 80 AND OVER; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 0033978027     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00400-8     Document Type: Article

References (36)

1. Isaacs S.D., Kiemeney L.A.L.M., Baffoe-Bonnie A., et al. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst. 87:1995;991-996.
2. Carter B.S., Beaty T.H., Steinberg G.D., et al. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA. 89:1992;3367-3371.
3. Carter B.S., Bova G.S., Beaty T.H., et al. Hereditary prostate cancer epidemiologic and clinical features . J Urol. 150:1993;797-802.
4. Smith J.R., Freije D., Carpten J.D., et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by genome-wide search. Science. 274:1996;1371-1374.
5. Cooney K.A., McCarthy J.D., Lange E., et al. Prostate cancer susceptibility locus on chromosome 1q a confirmatory study . J Natl Cancer Inst. 89:1997;955-959.
6. Hsieh C.-L., Oakley-Girvan I., Gallagher R.P., et al. Prostate cancer susceptibility locus on chromosome 1q a confirmatory study . J Natl Cancer Inst. 89:1997;1893-1894.
7. Gronberg H., Smith J., Emanuelsson M., et al. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. Am J Hum Genet. 65:1999;134-140.
8. Grönberg H., Isaacs S.D., Smith J.R., et al. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA. 278:1997;1251-1255.
9. Berthon P., Valeri A., Cohen-Akenine A., et al. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet. 62:1998;1416-1424.
10. Xu J., Meyers D., Freije D., et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet. 20:1998;175-179.
11. Gibbs M., Stanford J.L., McIndoe R.A., et al. Evidence for a rare prostate cancer susceptibility locus at chromosome 1p36. Am J Hum Genet. 64:1999;776-787.
12. Bratt O., Kristoffersson U., Lundgren R., et al. Sons of men with prostate cancer their attitudes regarding possible inheritance of prostate cancer, screening and genetic testing . Urology. 50:1997;360-365.
13. Lerman C., Daly M., Masny A., et al. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 12:1994;843-850.
14. Lerman C., Seay J., Balshem A., et al. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet. 57:1995;385-392.
15. Struewing J.P., Lerman C., Kase R.G., et al. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev. 4:1995;169-173.
16. Lerman C., Marshall J., Audrain J., et al. Genetic testing for colon cancer susceptibility anticipated reactions of patients and challenges to providers . Int J Cancer (Pred Oncol). 69:1996;58-61.
17. Jacobsen P.B., Valdimarsdottir H.B., Brown K.L., et al. Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med. 59:1997;459-466.
18. Loader S., Levenkron J.C., Rowley P.T. Genetic testing for breast-ovarian cancer susceptibility a regional trial . Genet Testing. 2:1998;305-313.
19. Bluman L.G., Rimer B.K., Berry D.A., et al. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol. 17:1999;1040-1046.
20. Durfy S.J., Bowen D.J., McTiernan A., et al. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev. 8:1999;360-375.
21. Croyle R.T., Lerman C. Interest in genetic testing for colon cancer susceptibility cognitive and emotional correlates . Prev Med. 22:1993;284-292.
22. Chaliki H., Loader S., Levenkron J.C., et al. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health. 85:1995;1133-1135.
23. Andrykowski M.A., Munn R.K., Studts J.L. Interest in learning of personal genetic risk for cancer a general population survey . Prev Med. 25:1996;527-536.
24. Tambor E.S., Rimer B.K., Strigo T.S. Genetic testing for breast cancer susceptibility awareness and interest among women in the general population . Am J Med Genet. 68:1997;43-49.
25. Lerman C., Narod S., Schulman K., et al. BRCA1 testing in families with hereditary breast-ovarian cancer a prospective study of patient decision making and outcomes . JAMA. 275:1996;1885-1892.
26. Craufurd D., Dodge A., Kerzin-Storrar L., et al. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet. 2:1989;603-605.
27. Quaid K.A., Morris M. Reluctance to undergo predictive testing the case of Huntington disease . Am J Med Genet. 45:1993;41-45.
28. Bekker H., Modell M., Denniss G., et al. Uptake of cystic fibrosis testing in primary care supply push or demand pull? BMJ. 306:1993;1584-1586.
29. Tambor E.S., Bernhardt B.A., Chase G.A., et al. Offering cystic fibrosis carrier screening to an HMO population factors associated with utilization . Am J Hum Genet. 55:1994;626-637.
30. Cowen M.E., Kattan M.W., Miles B.J. A national survey of attitudes regarding participation in prostate carcinoma screening. Cancer. 78:1996;1952-1957.
31. Smith G.E., DeHaven M.J., Grundig J.P., et al. African-American males and prostate cancer assessing knowledge levels in the community . J Natl Med Assoc. 89:1997;387-391.
32. Mebane C., Gibbs T., Horm J. Current status of prostate cancer in North American black males. J Natl Med Assoc. 82:1990;782-788.
33. Lerman C., Biesecker B., Benkendorf J.L., et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst. 89:1997;148-157.
34. Hughes C., Gomez-Caminero A., Benkendorf J., et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns. 32:1997;51-62.
35. Lerman C., Hughes C., Benkendorf J.L., et al. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev. 8:1999;361-367.
36. Eschenbach A., Ho R., Murphy G.P., et al. American Cancer Society guidelines for the early detection of prostate cancer update 1997 . CA Cancer J Clin. 47:1997;261-264.